MTMadhavi Tripathi

Madhavi Tripathi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Madhavi Tripathi has a total of 321 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Sustained 177Lu-FAPI-2286 Retention in Graves’ Orbitopathy

    by Mohammad Umar, Nishikant Avinash Damle, Madhavi Tripathi, Rachna Meel, Sahil Agrawal

    A 39-year-old man suffering from Graves’ ophthalmopathy, which was resistant to steroids (with a clinical activity score of 5/7 and a moderate-severe EUGOGO grade), had a 68Ga-FAPI-46 PET/CT scan. This scan showed strong bilateral FAPI activity in the extraocular muscles, especially in the inferior recti, even though his visual acuity remained normal. A later low-dose 177Lu-FAPI-2286 retention study confirmed that the radiotracer stayed selectively within the recti. This example suggests that fibroblast activation protein-targeted theranostics could be a new way to image and possibly treat Graves’ orbitopathy.

  • Open Access

    The role of [18F] FDG PET/CT guided biopsy in fever of unknown origin: Diagnostic yield and impact on clinical management

    by Bhabani Shankar Nayak, Madhavi Tripathi, Aakash Aravindh, Geetanjali Arora, Apoorva Tyagi, Aman Tilak, Vrati Jain, Manish Soneja, Neeraj Nischal, Meher Chand Sharma, et al.

  • Open Access

    Comparative Evaluation of [68Ga]Ga-DOTA.SA.FAPi and [18F]FDG PET/CT in Metastatic Breast and Lung Cancer: Semiquantitative, Volumetric and Prognostic Assessment

    by Sulochana Sarswat, Sanjana Ballal, Madhav Prasad Yadav, Madhavi Tripathi, Prabhat Singh Malik, Sandeep R. Mathur, Frank Rösch, Chandrasekhar Bal

    Objective: To compare metastatic lesion detection on [68Ga]Ga-DOTA.SA.FAPi and [18F]FDG PET/CT in metastatic breast and lung cancers and to assess the relationship between PET-derived imaging parameters and progression-free survival (PFS). Methods: In this prospective dual-cohort study, 45 patients (23 breast cancer, 22 lung adenocarcinoma) underwent paired [68Ga]Ga-DOTA.SA.FAPi and [18F]FDG PET/CT within four weeks. Semiquantitative (SUVmax, SUVmean) and volumetric (MTV, TLG, STV, TLF) PET parameters were measured. Metastatic detection was compared, and correlations with PFS were assessed. Results: In breast cancer, [18F]FDG demonstrated higher primary tumor uptake, whereas [68Ga]Ga-DOTA.SA.FAPi showed lower background activity, resulting in higher tumor-to-background ratios for brain and bone metastases. Whole-body volumetric indices (wbTLG, wbTLF) showed strong inverse correlations with PFS. In lung adenocarcinoma, volumetric FAPi-derived parameters (wbTLF, wbSTV) demonstrated modest but significant correlations with PFS. [68Ga]Ga-DOTA.SA.FAPi PET/CT detected more brain metastases than [18F]FDG PET/CT in both cohorts (breast: 15/15 vs. 8/15; lung: 14/14 vs. 4/14). Conclusions: [68Ga]Ga-DOTA.SA.FAPi and [18F]FDG PET/CT provide complementary diagnostic and prognostic information. In metastatic breast cancer, FAPi-derived volumetric parameters strongly correlate with PFS and improve detection of brain metastases. In lung adenocarcinoma, [68Ga]Ga-DOTA.SA.FAPi PET/CT offers low background uptake and prognostically relevant stromal metrics. These findings support a potential role for integrating [68Ga]Ga-DOTA.SA.FAPi PET/CT into disease staging, prognostication, and treatment monitoring. This study did not involve prospective assignment to health-related interventions and therefore did not require clinical trial registration.

  • Open Access

    Comparative Evaluation of [68Ga]Ga-DOTA.SA.FAPi and [18F]FDG PET/CT in Metastatic Breast and Lung Cancer: Semiquantitative, Volumetric and Prognostic Assessment

    by Sulochana Sarswat, Sanjana Ballal, Madhav Prasad Yadav, Madhavi Tripathi, Prabhat Malik, Sandeep Mathur, Frank Rösch, Chandrasekhar Bal

    Objective: To compare metastatic lesion detection on [68Ga]Ga-DOTA.SA.FAPi and [18F]FDG PET/CT in metastatic breast and lung cancers and to assess the relationship between PET-derived imaging parameters and progression-free survival (PFS). Methods: In this prospective dual-cohort study, 45 patients (23 breast cancer, 22 lung adenocarci-noma) underwent paired [68Ga]Ga-DOTA.SA.FAPi and [18F]FDG PET/CT within four weeks. Semiquantitative (SUVmax, SUVmean) and volumetric (MTV, TLG, STV, TLF) PET parameters were measured. Metastatic detection was compared, and correlations with PFS were assessed. Results: In breast cancer [18F]FDG demonstrated higher primary tu-mor uptake, whereas 68Ga-FAPi showed lower background activity, resulting in higher tumor-to-background ratios for brain and bone metastases. Whole-body volumetric indi-ces (wbTLG, wbTLF) showed strong inverse correlations with PFS. In lung adenocarcino-ma, volumetric FAPi-derived parameters (wbTLF, wbSTV) demonstrated modest but sig-nificant correlations with PFS. [68Ga]Ga-DOTA.SA.FAPi PET/CT detected more brain me-tastases than [18F]FDG PET/CT in both cohorts (breast: 15/15 vs. 8/15; lung: 14/14 vs. 4/14). Conclusions: [68Ga]Ga-DOTA.SA.FAPi and [18F]FDG PET/CT provide comple-mentary diagnostic and prognostic information. In metastatic breast cancer, FAPi-derived volumetric parameters strongly correlate with PFS and improve detection of brain metas-tases. In lung adenocarcinoma, [68Ga]Ga-DOTA.SA.FAPi PET/CT offers low background uptake and prognostically relevant stromal metrics. These findings support a potential role for integrating [68Ga]Ga-DOTA.SA.FAPi PET/CT into disease staging, prognostica-tion, and treatment monitoring. This study did not involve prospective assignment to health-related interventions and therefore did not require clinical trial registration.

  • Open Access

    Comparative Effect of Normal Protein and Low Protein Diet on Renal Function Reserve in Patients of Chronic Kidney Disease Stage 3 And 4: A Randomised Controlled Study

    by Varuna Yadav, Himansu Mahapatra, Madhavi Tripathi, Lalit Pursnani, Muthukumar B, Renju Binoy, Vipin Dev, Disha Arora, Hari Prasad Mk

    Background: Renal functional reserve (RFR), defined as the difference between peak and baseline glomerular filtration rate (GFR), reflects the adaptive capacity of the kidney. This study evaluated how normal protein diet (NPD) and low protein diet (LPD) affect changes in both absolute (RFR abs ) and relative (RFR % ) RFR, as well as rate of GFR decline over six months in patients with CKD stages 3 and 4. Methodology: This six‑month randomized controlled trial enrolled adults (>18 years) with stage 3–4 CKD. Baseline assessments included clinical and laboratory parameters, eGFR, Creatinine clearance (CrCl) and two‑plasma technetium-99m Diethylenetriamine pentaacetic acid ( 99m Tc‑DTPA) method before and after a 1 g/kg protein load to calculate RFR abs and RFR % . Patients were randomized to either a normal protein diet (0.8 g/kg/day) or a low protein diet (0.6 g/kg/day). Dietary adherence monitored by recall, record and 24‑hour urinary urea nitrogen. All parameters were repeated at six months to compare RFR abs and RFR % changes by both measured GFR methods between diet groups. Patients having RFR below median value of the study population were considered to have low renal reserve; risk factors of low RFR were also assessed. Results: Of 135 patients (64 NPD, 71 LPD), there was significant increase in measured GFR after protein loading in both groups at baseline and at six months (p < 0.001). The magnitude of increase in GFR after protein loading didn’t differ between groups at baseline (p = 0.88), but significantly high in LPD group at six months (p = 0.03). The decline in RFR was significantly smaller in LPD than NPD after six months by both the methods of RFR estimation (RFR abs (DTPA): p = 0.002; RFR % (DTPA): p = 0.001 and RFR abs (CrCl): p=0.046; RFR % (CrCl): p=0.021; respectively), with no significant difference in eGFR change between groups. Lower baseline GFR, higher proteinuria and increased age were independent risk factors for low renal reserve. Conclusion: LPD preserved both absolute and relative RFR compared to NPD. Decline in RFR preceded fall in GFR, making it a potential early biomarker for CKD progression. Trial registration: - Clinical Trial Registry (India) CTRI – CTRI/2024/08/071864 dated 2 nd August 2024 Key words: Chronic kidney disease, creatinine clearance, technetium-99m Diethylenetriamine pentaacetic acid, low protein diet, normal protein diet, renal function reserve

  • Open Access

    FDG PET/CT Guided Metabolic Biopsy in Histologic Transformation of Follicular Lymphoma

    by Sivasankar Kanankulam Velliangiri, Madhavi Md Tripathi, Bhabani Shankar Mbbs Nayak, Vrati Bsc Jain, Chandrasekhar Md Bal

    Follicular lymphoma is an indolent form of non-Hodgkin lymphoma arising from the germinal center B cells. Histologic transformation to aggressive form of lymphoma occurs in ~15% of patients, with diffuse large B-cell lymphoma (DLBCL) being the most common type of histologic transformation. Unlike indolent follicular lymphoma, histologic transformation is associated with poor prognosis requiring aggressive treatment. Here we discuss the role of FDG PET/CT guided metabolic biopsy in a woman with known follicular lymphoma on treatment.

  • Open Access

    Comparative Assessments of PET and ASL MR Perfusion in the Evaluation of Early Dementia

    by Savyasachi Jain, Shailesh B Gaikwad, Bheru Dan Charan, Anu Gupta, Madhvi Tripathy

    Background: Overtly morbid dementing diseases have a prodromal MCI (mild cognitive impairment) phase which is crucial to recognize. Clinical scores provide an easy bedside assessment tool for holistic cognitive evaluation but fail to provide lead time. While routine biomarkers of brain atrophy are late to appear, non-contrast MRI perfusion studies like ASL may serve as a valuable alternative to 18F-FDG-PET for the recognition and classification of the degree of neurodegeneration in individuals with MCI, especially when FDG-PET is not available. Our study adds confidence as we noted brain regions where PET-ASL concordance was most robust and devised concordance with ACE-3 scores.Material and methods: We conducted a prospective study from Jan 2021 to Jan 2024. Cases were selected based on the inclusion and exclusion criteria, which have objective cognitive impairment. Healthy controls were selected. MRI and PET scans were performed in all cases. Perfusion values of arterial spine labeling, PET, and clinical examination were recorded.Results: We included 33 patients and 15 healthy controls in the study. We compared ASL and PET for all selected individuals. Our study showed that ASL can detect a hypo-perfusion region with a 91% sensitivity, 85.98% specificity, 89.8% PPV, and 87.62% NPV, with a diagnostic accuracy of 88.9%.Conclusion: ASL was a dependable replacement for the gold-standard FDG-PET. ASL may serve as a valuable alternative to 18F-FDG-PET for classifying the degree of neurodegeneration in individuals with prodromal AD, especially when FDG-PET is unavailable.

  • Open Access

    Incidental Finding of Acute Appendicitis on FDG PET/CT in Breast Carcinoma

    by Bela Jain, Yogita Khandelwal, Nishikant Avinash Damle, Madhavi Tripathi, Chandrasekhar Bal

    The interpretation of F-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) scans can be confounded by incidental findings, as illustrated in this case of a 47-year-old woman with a history of breast carcinoma. Following neoadjuvant chemotherapy and mastectomy, she underwent FDG PET/CT for disease evaluation, revealing unexpected hypermetabolic activity in the right iliac fossa corresponding to acute appendicitis. Thus, FDG PET/CT has the potential to uncover treatable conditions beyond cancer and imaging findings need clinical correlation.